Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors. | J Exp Clin Cancer Res | 2022 | 35971164 | PubTator, text mining | PubMed |
| Editorial: Impact of radiotherapy and radiosurgery on neuro-oncology. | Front Oncol | 2022 | 35957873 | PubTator, text mining | PubMed |
| Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico. | Int J Mol Sci | 2022 | 35955700 | PubTator, text mining | PubMed |
| DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective. | Cancers (Basel) | 2022 | 35954483 | PubTator, text mining | PubMed |
| Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. | JCO Precis Oncol | 2022 | 35952322 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Primary retroperitoneal perirenal CIC rearrangement sarcoma: A case report. | Oncol Lett | 2022 | 35949589 | PubTator, text mining | PubMed |
| Patterns of structural variation define prostate cancer across disease states. | JCI Insight | 2022 | 35943799 | PubTator, text mining | PubMed |
| Serum Extracellular Vesicle Stratifin Is a Biomarker of Perineural Invasion in Patients With Colorectal Cancer and Predicts Worse Prognosis. | Front Oncol | 2022 | 35936690 | PubTator, text mining | PubMed |
| Transcriptional and reverse transcriptional regulation of host genes by human endogenous retroviruses in cancers. | Front Microbiol | 2022 | 35928153 | PubTator, text mining | PubMed |
| Role of ferroptosis-related genes in coronary atherosclerosis and identification of key genes: integration of bioinformatics analysis and experimental validation. | BMC Cardiovasc Disord | 2022 | 35906548 | PubTator, text mining | PubMed |
| Reliable epithelial-mesenchymal transition biomarkers for colorectal cancer detection. | Biomark Med | 2022 | 35892269 | PubTator, text mining | PubMed |
| Noncanonical function of Capicua as a growth termination signal in Drosophila oogenesis. | Proc Natl Acad Sci U S A | 2022 | 35881788 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung Cancer. | Front Immunol | 2022 | 35874785 | PubTator, text mining | PubMed |
| Identification of fusions with potential clinical significance in melanoma. | Mod Pathol | 2022 | 35871080 | PubTator, text mining | PubMed |
| Unravelling genetic variants of a swedish family with high risk of prostate cancer. | Hered Cancer Clin Pract | 2022 | 35870994 | PubTator, text mining | PubMed |
| Effect of benzo[a]pyrene on proliferation and metastasis of oral squamous cell carcinoma cells: A transcriptome analysis based on RNA-seq. | Environ Toxicol | 2022 | 35870112 | PubTator, text mining | PubMed |
| TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. | Int J Biol Sci | 2022 | 35864968 | PubTator, text mining | PubMed |
| Etv2 regulates enhancer chromatin status to initiate Shh expression in the limb bud. | Nat Commun | 2022 | 35864091 | PubTator, text mining | PubMed |
| ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. | Front Immunol | 2022 | 35860243 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=26